What's the average/range of the total number of reads in 454 library?
Unconfigured Ad
Collapse
X
-
-
The number will depend on the type of chemistry, the number of regions you are using (e.g., whole plate, quads, etc.), loss of quality that you willing to tolerate within the sequencing, the quality of your starting material, etc.
Just to throw out some numbers our last titanium run with 4 different experiments (samples) on it gave us:
136538 reads at 553 bases with std. deviation of 332 bases.
392301 reads at 298 std. dev. 137 bases
369737 reads at 318 std. dev. 154 bases
391092 reads at 325 std. dev. 154 bases
So roughly 1.3 million reads of around 300 bases or ~400 M base pairs.
-
I really depends a lot on what you're doing. Our first run with a bacteria on the titanium got 1,371,195 reads, avg 397.4, std. dev. 135. In total 505Mb.
But now we're doing runs with array enrichment and we get about 100Mb less per run. Although I've been told that a new protocol for array enrichment will perform much better.
Comment
-
Which enrichment system are you using? I was thinking of using Nimblegen, but it seams too expensive, so I am starting with some test with the Combimatrix array first. Anyone using Combimatrix for seq enrichemnt??
Comment
-
I was thinking of doing the same thing, but my concern is if it is possible to tag the samples before doing the enrichment. My target is <<5Mb, so I was thinking of using the Nimblegen array with a high tilling (many copies of the same few probes targeting 100kb per sample) so that I could enrich many samples all together.
I was wondering if you ever tried anything like that?
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
14 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
13 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
34 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
41 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment